Mercury Laboratories [MERCURYLAB] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Mercury Laboratories

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mercury Laboratories wins in 6 metrics, Sun Pharmaceutical wins in 14 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMercury LaboratoriesSun PharmaceuticalBetter
P/E Ratio (TTM)26.0936.74Mercury Laboratories
Price-to-Book Ratio1.845.30Mercury Laboratories
Debt-to-Equity Ratio10.183.26Sun Pharmaceutical
PEG Ratio0.14-1.89Sun Pharmaceutical
EV/EBITDA13.9023.33Mercury Laboratories
Profit Margin (TTM)4.93%19.29%Sun Pharmaceutical
Operating Margin (TTM)8.34%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)8.34%24.34%Sun Pharmaceutical
Return on Equity5.87%15.08%Sun Pharmaceutical
Return on Assets (TTM)4.23%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-50.39M$119.44BSun Pharmaceutical
Dividend Yield0.82%1.26%Sun Pharmaceutical
1-Year Return-17.07%-14.60%Sun Pharmaceutical
Price-to-Sales Ratio (TTM)1.297.11Mercury Laboratories
Enterprise Value$1.02B$3,578.34BSun Pharmaceutical
EV/Revenue Ratio1.346.65Mercury Laboratories
Gross Profit Margin (TTM)60.02%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$638$224Mercury Laboratories
Earnings per Share (Diluted)$31.43$43.39Sun Pharmaceutical
Beta (Stock Volatility)0.570.31Sun Pharmaceutical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Mercury Laboratories vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Mercury Laboratories
Sun Pharmaceutical
Mercury Laboratories Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mercury Laboratories3.66%3.84%1.80%-0.74%1.18%-4.50%
Sun Pharmaceutical-0.31%2.80%3.33%-2.89%-7.84%-13.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mercury Laboratories-17.07%42.15%92.55%110.81%2,274.30%2,274.30%
Sun Pharmaceutical-14.60%70.78%218.03%80.00%690.16%2,608.73%

News Based Sentiment: Mercury Laboratories vs Sun Pharmaceutical

Mercury Laboratories

News based Sentiment: MIXED

September presented a mixed bag for Mercury Laboratories, with a positive valuation upgrade countered by concerns over profitability and a declining share price over the past year. The volatility and conflicting signals make it a significant month for investors to assess the company's direction.

View Mercury Laboratories News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Mercury Laboratories vs Sun Pharmaceutical

MetricMERCURYLABSUNPHARMA
Market Information
Market Cap i₹1.02B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i282,839,112
90 Day Avg. Volume i1382,655,594
Last Close₹850.00₹1,631.20
52 Week Range₹736.00 - ₹1,190.00₹1,548.00 - ₹1,952.25
% from 52W High-28.57%-16.45%
All-Time High₹1,303.00 (Jan 08, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-34.77%-16.79%
Growth Metrics
Quarterly Revenue Growth0.09%0.10%
Quarterly Earnings Growth1.83%-0.20%
Financial Health
Profit Margin (TTM) i0.05%0.19%
Operating Margin (TTM) i0.08%0.24%
Return on Equity (TTM) i0.06%0.15%
Debt to Equity (MRQ) i10.183.26
Cash & Liquidity
Book Value per Share (MRQ)₹446.41₹300.99
Cash per Share (MRQ)₹12.97₹108.88
Operating Cash Flow (TTM) i₹-12,625,000₹110.84B
Levered Free Cash Flow (TTM) i₹31.45M₹109.29B
Dividends
Last 12-Month Dividend Yield i0.82%1.26%
Last 12-Month Dividend i₹7.00₹21.00

Valuation & Enterprise Metrics Analysis: Mercury Laboratories vs Sun Pharmaceutical

MetricMERCURYLABSUNPHARMA
Price Ratios
P/E Ratio (TTM) i26.0936.74
Forward P/E iN/A48.79
PEG Ratio i0.14-1.89
Price to Sales (TTM) i1.297.11
Price to Book (MRQ) i1.845.30
Market Capitalization
Market Capitalization i₹1.02B₹3.92T
Enterprise Value i₹1.02B₹3.58T
Enterprise Value Metrics
Enterprise to Revenue i1.346.65
Enterprise to EBITDA i13.9023.33
Risk & Other Metrics
Beta i0.570.31
Book Value per Share (MRQ) i₹446.41₹300.99

Financial Statements Comparison: Mercury Laboratories vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MERCURYLABSUNPHARMA
Revenue/Sales i₹181.35M₹137.86B
Cost of Goods Sold i₹72.50M₹28.15B
Gross Profit i₹108.85M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹15.12M₹33.72B
EBITDA i₹25.36M₹47.66B
Pre-Tax Income i₹15.47M₹31.73B
Income Tax i₹5.80M₹8.70B
Net Income (Profit) i₹9.68M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MERCURYLABSUNPHARMA
Cash & Equivalents i₹3.32M₹102.69B
Total Current Assets i₹401.60M₹526.24B
Total Current Liabilities i₹150.76M₹181.94B
Long-Term Debt i₹37.83M₹3.58B
Total Shareholders Equity i₹535.69M₹724.86B
Retained Earnings i₹86.56M₹578.62B
Property, Plant & Equipment i₹85.40M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MERCURYLABSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMERCURYLABSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i282,839,112
Average Daily Volume (90 Day) i1382,655,594
Shares Outstanding i1.20M2.40B
Float Shares i166,4161.04B
% Held by Insiders i0.86%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Mercury Laboratories vs Sun Pharmaceutical

MetricMERCURYLABSUNPHARMA
Last 12-Month Dividend i₹7.00₹21.00
Last 12-Month Dividend Yield i0.82%1.26%
3-Year Avg Annual Dividend i₹4.67₹14.67
3-Year Avg Dividend Yield i0.43%0.46%
3-Year Total Dividends i₹14.00₹44.00
Ex-Dividend DateAug 06, 2025Jul 07, 2025